{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:00:01Z","timestamp":1789419601189,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,9,30]],"date-time":"2008-09-30T00:00:00Z","timestamp":1222732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1038\/ncprheum0919","type":"journal-article","created":{"date-parts":[[2008,9,30]],"date-time":"2008-09-30T03:58:53Z","timestamp":1222747133000},"page":"615-620","source":"Crossref","is-referenced-by-count":124,"title":["A case of macrophage activation syndrome successfully treated with anakinra"],"prefix":"10.1038","volume":"4","author":[{"given":"Alison","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athimalaipet V","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,30]]},"reference":[{"key":"BFncprheum0919_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/BOR.0b013e32825a6a79","volume":"19","author":"A Kelly","year":"2007","unstructured":"Kelly A and Ramanan AV (2007) Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 19: 477\u2013481","journal-title":"Curr Opin Rheumatol"},{"key":"BFncprheum0919_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/art.20198","volume":"50","author":"AA Grom","year":"2004","unstructured":"Grom AA (2004) Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 50: 689\u2013698","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0919_CR3","first-page":"451","volume":"11","author":"JL St\u00e9phan","year":"1993","unstructured":"St\u00e9phan JL  et al. (1993) Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11: 451\u2013456","journal-title":"Clin Exp Rheumatol"},{"key":"BFncprheum0919_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00002281-200209000-00012","volume":"14","author":"A Ravelli","year":"2002","unstructured":"Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14: 548\u2013552","journal-title":"Curr Opin Rheumatol"},{"key":"BFncprheum0919_CR5","first-page":"1620","volume":"25","author":"BJ Bloom","year":"1998","unstructured":"Bloom BJ  et al. (1998) Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis. J Rheumatol 25: 1620\u20131625","journal-title":"J Rheumatol"},{"key":"BFncprheum0919_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0049-3848(98)00145-5","volume":"92","author":"S Gallistl","year":"1998","unstructured":"Gallistl S  et al. (1998) Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity. Thromb Res 92: 267\u2013272","journal-title":"Thromb Res"},{"key":"BFncprheum0919_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/art.1780280304","volume":"28","author":"JP Scott","year":"1985","unstructured":"Scott JP  et al. (1985) Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum 28: 256\u2013261","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0919_CR8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","volume":"56","author":"J Bleesing","year":"2007","unstructured":"Bleesing J  et al. (2007) The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 56: 965\u2013971","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0919_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/pbc.21564","volume":"51","author":"A Gupta","year":"2008","unstructured":"Gupta A  et al. (2008) The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 51: 402\u2013404","journal-title":"Pediatr Blood Cancer"},{"key":"BFncprheum0919_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI  et al. (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48: 124\u2013131","journal-title":"Pediatr Blood Cancer"},{"key":"BFncprheum0919_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","volume":"146","author":"A Ravelli","year":"2005","unstructured":"Ravelli A  et al. (2005) Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146: 598\u2013604","journal-title":"J Pediatr"},{"key":"BFncprheum0919_CR12","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM  et al. (2007) Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34: 1133\u20131138","journal-title":"J Rheumatol"},{"key":"BFncprheum0919_CR13","first-page":"2513","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV and Schneider R (2003) Macrophage activation syndrome\u2014what's in a name! J Rheumatol 30: 2513\u20132516","journal-title":"J Rheumatol"},{"key":"BFncprheum0919_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"SP Sawhney","year":"2001","unstructured":"Sawhney SP  et al. (2001) Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 85: 421\u2013426","journal-title":"Arch Dis Child"},{"key":"BFncprheum0919_CR15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","volume":"40","author":"JL St\u00e9phan","year":"2001","unstructured":"St\u00e9phan JL  et al. (2001) Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 40: 1285\u20131292","journal-title":"Rheumatology (Oxford)"},{"key":"BFncprheum0919_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ajh.1141","volume":"68","author":"U Emmenegger","year":"2001","unstructured":"Emmenegger U  et al. (2001) Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 68: 4\u201310","journal-title":"Am J Hematol"},{"key":"BFncprheum0919_CR17","first-page":"230","volume":"132","author":"U Emmenegger","year":"2002","unstructured":"Emmenegger U  et al. (2002) Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 132: 230\u2013236","journal-title":"Swiss Med Wkly"},{"key":"BFncprheum0919_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/rheumatology\/34.9.888","volume":"34","author":"D Fishman","year":"1995","unstructured":"Fishman D  et al. (1995) Successful management of reactive haemophagocytic syndrome in systemic- onset juvenile chronic arthritis. Br J Rheumatol 34: 888","journal-title":"Br J Rheumatol"},{"key":"BFncprheum0919_CR19","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V  et al. (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201: 1479\u20131486","journal-title":"J Exp Med"},{"key":"BFncprheum0919_CR20","first-page":"2071","volume":"31","author":"JW Verbsky","year":"2004","unstructured":"Verbsky JW and White AJ (2004) Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J Rheumatol 31: 2071\u20132075","journal-title":"J Rheumatol"},{"key":"BFncprheum0919_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P  et al. (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48: 1093\u20131101","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0919_CR22","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"G Horneff","year":"2004","unstructured":"Horneff G  et al. (2004) The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 63: 1638\u20131644","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0919_CR23","first-page":"935","volume":"32","author":"Y Kimura","year":"2005","unstructured":"Kimura Y  et al. (2005) Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. J Rheumatol 32: 935\u2013942","journal-title":"J Rheumatol"},{"key":"BFncprheum0919_CR24","first-page":"2120","volume":"28","author":"S Prahalad","year":"2001","unstructured":"Prahalad S  et al. (2001) Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 28: 2120\u20132124","journal-title":"J Rheumatol"},{"key":"BFncprheum0919_CR25","first-page":"401","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV and Schneider R (2003) Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 30: 401\u2013403","journal-title":"J Rheumatol"},{"key":"BFncprheum0919_CR26","first-page":"79","volume":"3","author":"A Lurati","year":"2005","unstructured":"Lurati A  et al. (2005) Macrophage activation syndrome (MAS) during anti-IL1 receptor therapy (anakinra) in a patient affected by systemic onset juvenile idiopathic arthritis (SoJIA): a report and review of the literature. Pediatr Rheumatol Online J 3: 79\u201385","journal-title":"Pediatr Rheumatol Online J"},{"key":"BFncprheum0919_CR27","first-page":"2081","volume":"33","author":"EM Behrens","year":"2006","unstructured":"Behrens EM  et al. (2006) Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis. J Rheumatol 33: 2081\u20132084","journal-title":"J Rheumatol"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0919","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:22Z","timestamp":1684430242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,30]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["BFncprheum0919"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0919","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1162147.622617","asserted-by":"object"}]},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,30]]}}}